Back to series
CPD Approval: Atopic dermatitis (eczema) in patients with darker skin tones
MedShr Editor

CPD Approval: Atopic dermatitis (eczema) in patients with darker skin tones

MedShr Editor

This module contains content funded by Pfizer Ltd and developed in partnership with MedShr for UK Healthcare Professionals only.
Pfizer employees do not have access to the MedShr platform.


Job Code: PP-UNP-GBR-10765
Date of Preparation: May 2025


Atopic dermatitis (AD, eczema) is a common condition. However, patients with darker skin tones are more likely to be misdiagnosed or have treatment delays.


This learning module explores how AD presents in patients with darker skin tones, the psychosocial effects and the importance of a holistic approach to management.


The module will also cover available treatments, discuss healthcare disparities, and explore current challenges surrounding topical steroid withdrawal and information on social media.

This module contains multiple choice questions.
Sign up to start learning
,